Brookfield Asset Management Operating Cash Flow decreased by 52.1% to $338.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 196.5%, from $114.00M to $338.00M. Over 2 years (FY 2023 to FY 2025), Operating Cash Flow shows an upward trend with a 20.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $359.75M | $359.75M | $359.75M | $359.75M | $516.00M | $393.00M | $567.00M | $136.00M | $114.00M | $529.00M | $745.00M | $706.00M | $338.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +43.4% | -23.8% | +44.3% | -76.0% | -16.2% | +364.0% | +40.8% | -5.2% | -52.1% |
| YoY Change | — | — | — | — | +43.4% | +9.2% | +57.6% | -62.2% | -77.9% | +34.6% | +31.4% | +419.1% | +196.5% |